Nexalis Therapeutics LimitedASX: NX1

Significant Milestone - Completion of IRX211 Phase 1 Trial

Dec 4, 2023 at 4:05 AM UTC · Issued by Nexalis Therapeutics Limited

Nexalis Therapeutics Limited has released a press release.

View Attachment